The research, published in the journal Nature, shows the new class of anti-cancer drugs, in effect, put cancer cells permanently to sleep.The process of stopping the growth of tumours occurs without damaging any cell's DNA, which occurs in conventional treatments such as chemotherapy and radiotherapy.
The development of the drugs has been a joint effort between the Walter and Eliza Hall Institute of Medical Research, Monash University, Cancer Therapeutics CRC, The University of Melbourne, Peter MacCallum Cancer Centre and the CSIRO.

